{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:00:53Z","timestamp":1770328853079,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40264-022-01147-6","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T13:02:36Z","timestamp":1647694956000},"page":"379-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9026-5958","authenticated-orcid":false,"given":"Benedikte Irene","family":"von Osmanski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-7822","authenticated-orcid":false,"given":"Astrid Blicher","family":"Schelde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-147X","authenticated-orcid":false,"given":"Espen","family":"Jimenez-Solem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-7520","authenticated-orcid":false,"given":"Martin Erik","family":"Nyeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-1567","authenticated-orcid":false,"given":"Henrik","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,19]]},"reference":[{"key":"1147_CR1","unstructured":"Omniscan-skandalen \u00e5r for \u00e5r. Dagens Medicin 2010. https:\/\/dagensmedicin.dk\/omniscan-skandalen-ar-for-ar\/ (Accessed Dec 21, 2021)."},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1681\/ASN.2006060601","volume":"17","author":"P Marckmann","year":"2006","unstructured":"Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. JASN. 2006;17:2359\u201362. https:\/\/doi.org\/10.1681\/ASN.2006060601.","journal-title":"JASN"},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","volume":"21","author":"T Grobner","year":"2006","unstructured":"Grobner T. Gadolinium\u2014a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfk062.","journal-title":"Nephrol Dial Transplant"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","volume":"356","author":"SE Cowper","year":"2000","unstructured":"Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet. 2000;356:1000\u20131. https:\/\/doi.org\/10.1016\/S0140-6736(00)02694-5.","journal-title":"Lancet"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/ejhpharm-2012-000171","volume":"20","author":"AR Lander","year":"2013","unstructured":"Lander AR, Blicher TM, Jimenez-Solem E, Jespersen M, Kampmann JP, Christensen HR. Introducing an adverse drug event manager. Eur J Hosp Pharm. 2013;20:78\u201381. https:\/\/doi.org\/10.1136\/ejhpharm-2012-000171.","journal-title":"Eur J Hosp Pharm"},{"key":"1147_CR6","first-page":"A5315","volume":"64","author":"S Vinther","year":"2017","unstructured":"Vinther S, Klarskov P, Borgeskov H, Dars\u00f8 P, Christophersen AK, Borck B, et al. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions. Dan Med J. 2017;64:A5315.","journal-title":"Dan Med J"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40290-015-0102-x","volume":"29","author":"FKH S\u00f8rup","year":"2015","unstructured":"S\u00f8rup FKH, Jacobsen CB, Jimenez-Solem E. Increasing the number of spontaneous ADE reports in a Danish region: a retrospective analysis. Pharm Med. 2015;29:211\u20137. https:\/\/doi.org\/10.1007\/s40290-015-0102-x.","journal-title":"Pharm Med"},{"key":"1147_CR8","unstructured":"Sundheds-og \u00c6ldreministeriet. Bekendtg\u00f8relse om indberetning af bivirkninger ved l\u00e6gemidler m.m; 2015. https:\/\/www.retsinformation.dk\/Forms\/R0710.aspx?id=176092 (Accessed Apr 9, 2020)."},{"key":"1147_CR9","unstructured":"Sundheds-og \u00c6ldreministeriet. Bekendtg\u00f8relse om indberetning af bivirkninger ved l\u00e6gemidler m.m. 2003. https:\/\/www.retsinformation.dk\/eli\/lta\/2003\/589 (Accessed Nov 10, 2021)."},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351. https:\/\/doi.org\/10.1056\/NEJMoa0905561.","journal-title":"N Engl J Med"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883\u201391. https:\/\/doi.org\/10.1056\/NEJMoa1009638.","journal-title":"N Engl J Med"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1107039.","journal-title":"N Engl J Med"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385\u201396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003.","journal-title":"Drug Saf"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390. https:\/\/doi.org\/10.2147\/CLEP.S91125.","journal-title":"Clin Epidemiol"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol. 2017;46:798\u2013798f. https:\/\/doi.org\/10.1093\/ije\/dyw213.","journal-title":"Int J Epidemiol"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139. https:\/\/doi.org\/10.1007\/s10654-014-9930-3.","journal-title":"Eur J Epidemiol"},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ije\/dyw116","volume":"45","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Hallas J, Laursen M, Friis S. Data Resource Profile: Danish online drug use statistics (MEDSTAT). Int J Epidemiol. 2016;45:1401\u20131402g. https:\/\/doi.org\/10.1093\/ije\/dyw116.","journal-title":"Int J Epidemiol"},{"key":"1147_CR18","unstructured":"WHO | 3. Defined Daily Dose (DDD). WHO n.d. http:\/\/www.who.int\/medicines\/regulation\/medicines-safety\/toolkit_ddd\/en\/ (Accessed Apr 9, 2020)."},{"key":"1147_CR19","unstructured":"Interactive Adverse Drug Reaction overviews. Danish Medicines Agency n.d. https:\/\/laegemiddelstyrelsen.dk\/en\/sideeffects\/side-effects-of-medicines\/interactive-adverse-drug-reaction-overviews\/ (Accessed Apr 9, 2020)."},{"key":"1147_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S. The Medical Dictionary for Regulatory Activities (MedDRA). Drug Saf. 1999;20:109\u201317. https:\/\/doi.org\/10.2165\/00002018-199920020-00002.","journal-title":"Drug Saf"},{"key":"1147_CR21","unstructured":"MedDRA Hierarchy | MedDRA n.d. https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy (Accessed June 22, 2020)."},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494811399956","volume":"39","author":"LC Thygesen","year":"2011","unstructured":"Thygesen LC, Daasnes C, Thaulow I, Br\u00f8nnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011;39:12\u20136. https:\/\/doi.org\/10.1177\/1403494811399956.","journal-title":"Scand J Public Health"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/CLEP.S197251","volume":"11","author":"A Sonne","year":"2019","unstructured":"Sonne A, Andersen JB, Rasmussen LS. The positive predictive value of spontaneous subarachnoid hemorrhage diagnoses in the Danish National Patient Register. Clin Epidemiol. 2019;11:323\u201331. https:\/\/doi.org\/10.2147\/CLEP.S197251.","journal-title":"Clin Epidemiol"},{"key":"1147_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2147\/CLEP.S167576","volume":"10","author":"SM Hald","year":"2018","unstructured":"Hald SM, Kring Sloth C, Hey SM, Madsen C, Nguyen N, Garc\u00eda Rodr\u00edguez LA, et al. Intracerebral hemorrhage: positive predictive value of diagnosis codes in two nationwide Danish registries. Clin Epidemiol. 2018;10:941\u20138. https:\/\/doi.org\/10.2147\/CLEP.S167576.","journal-title":"Clin Epidemiol"},{"key":"1147_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.rec.2018.03.009","volume":"72","author":"C Escobar","year":"2019","unstructured":"Escobar C, Mart\u00ed-Almor J, P\u00e9rez Cabeza A, Mart\u00ednez-Zapata MJ. Direct oral anticoagulants versus vitamin K antagonists in real-life patients with atrial fibrillation. A systematic review and meta-analysis. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2019;72:305\u201316. https:\/\/doi.org\/10.1016\/j.rec.2018.03.009.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"1147_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2125.1992.tb04001.x","volume":"33","author":"J Hallas","year":"1992","unstructured":"Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol. 1992;33:61\u20138. https:\/\/doi.org\/10.1111\/j.1365-2125.1992.tb04001.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1147_CR27","first-page":"A4952","volume":"61","author":"M Bay-Nielsen","year":"2014","unstructured":"Bay-Nielsen M, Kampmann JP, Bisgaard T. Gastrointestinal bleedings during therapy with new oral anticoagulants are rarely reported. Dan Med J. 2014;61:A4952.","journal-title":"Dan Med J"},{"key":"1147_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14740338.2017.1323867","volume":"16","author":"YM Alatawi","year":"2017","unstructured":"Alatawi YM, Hansen RA. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2017;16:761\u20137. https:\/\/doi.org\/10.1080\/14740338.2017.1323867.","journal-title":"Expert Opin Drug Saf"},{"key":"1147_CR29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s40264-013-0115-x","volume":"36","author":"P Chhabra","year":"2013","unstructured":"Chhabra P, Chen X, Weiss SR. Adverse event reporting patterns of newly approved drugs in the USA in 2006: an analysis of FDA adverse event reporting system data. Drug Saf. 2013;36:1117\u201323. https:\/\/doi.org\/10.1007\/s40264-013-0115-x.","journal-title":"Drug Saf"},{"key":"1147_CR30","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/bcp.14342","volume":"86","author":"V Modgill","year":"2020","unstructured":"Modgill V, Dormegny L, Lewis DJ. Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: a lack of evidence for the Weber effect. Br J Clin Pharmacol. 2020;86:2393\u2013403. https:\/\/doi.org\/10.1111\/bcp.14342.","journal-title":"Br J Clin Pharmacol"},{"key":"1147_CR31","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0895-4356(02)00450-X","volume":"55","author":"J Hasford","year":"2002","unstructured":"Hasford J, Goettler M, Munter K-H, M\u00fcller-Oerlinghausen B. Physicians\u2019 knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55:945\u201350. https:\/\/doi.org\/10.1016\/S0895-4356(02)00450-X.","journal-title":"J Clin Epidemiol"},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/FAD.0000000000000035","volume":"311","author":"K Dalhoff","year":"2018","unstructured":"Dalhoff K, Andersen JT, Andersen JT, Jimenez-Solem E, Dalhoff KP. A new beginning: Adverse drug reaction manager: a way of increasing the number of spontaneous reporting. Adverse Drug React Bull. 2018;311:1203\u20136. https:\/\/doi.org\/10.1097\/FAD.0000000000000035.","journal-title":"Adverse Drug React Bull"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01147-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01147-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T17:08:20Z","timestamp":1650474500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01147-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,19]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01147-6","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,19]]},"assertion":[{"value":"11 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors have declared that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required in Denmark for anonymized registry-based studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data on adverse drug reaction reports received by the Danish Medicines Agency are publicly available through the interactive overview (access through ). Likewise, Danish drug sales statistics are publicly accessible through the web service MEDical STATistics (MEDSTAT) provided by the Danish Health Data Authority (accessed through ). The remaining data analyzed in the present study are held by the Danish Health Data Authority and were accessed through a secured online server. We are not allowed to pass on this data to any third parties.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Can be provided upon request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Authors HH, AS, BO and ES all contributed to the conception and design of the study. The data application process and data management were handled by authors HH, MN and BO. Analyses were performed by authors HH and BO. All authors participated in discussing and interpreting the data and results. Author BO drew up the first draft of the article, which was afterwards iteratively read and commented on by the remaining authors. The final version of the manuscript is approved by all authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}